418 related articles for article (PubMed ID: 25941011)
1. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection.
García-Niño WR; Zazueta C
Pharmacol Res; 2015 Jul; 97():84-103. PubMed ID: 25941011
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury.
Farbood Y; Sarkaki A; Dianat M; Khodadadi A; Haddad MK; Mashhadizadeh S
Life Sci; 2015 Mar; 124():120-7. PubMed ID: 25637685
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems.
Pavlova EL; Zografov NN; Simeonova LS
Biomed Pharmacother; 2016 Oct; 83():755-762. PubMed ID: 27479194
[TBL] [Abstract][Full Text] [Related]
4. Role of ellagic acid for the prevention and treatment of liver diseases.
Aishwarya V; Solaipriya S; Sivaramakrishnan V
Phytother Res; 2021 Jun; 35(6):2925-2944. PubMed ID: 33368795
[TBL] [Abstract][Full Text] [Related]
5. Nanoliposome-encapsulated ellagic acid prevents cyclophosphamide-induced rat liver damage.
Stojiljković N; Ilić S; Stojanović N; Janković-Veličković L; Stojnev S; Kocić G; Radenković G; Arsić I; Stojanović M; Petković M
Mol Cell Biochem; 2019 Aug; 458(1-2):185-195. PubMed ID: 31004308
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
8. Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture.
Buniatian GH
Cell Prolif; 2003 Dec; 36(6):307-19. PubMed ID: 14710849
[TBL] [Abstract][Full Text] [Related]
9. Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats.
Pari L; Sivasankari R
Fundam Clin Pharmacol; 2008 Aug; 22(4):395-401. PubMed ID: 18705750
[TBL] [Abstract][Full Text] [Related]
10. Chalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms.
Karimi-Sales E; Mohaddes G; Alipour MR
Pharmacol Res; 2018 Mar; 129():177-187. PubMed ID: 29175112
[TBL] [Abstract][Full Text] [Related]
11. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
[TBL] [Abstract][Full Text] [Related]
12. Ellagic acid ameliorates cisplatin induced hepatotoxicity in colon carcinogenesis.
Goyal Y; Koul A; Ranawat P
Environ Toxicol; 2019 Jul; 34(7):804-813. PubMed ID: 30953405
[TBL] [Abstract][Full Text] [Related]
13. Modulatory potential of ellagic acid, a natural plant polyphenol on altered lipid profile and lipid peroxidation status during alcohol-induced toxicity: a pathohistological study.
Devipriya N; Sudheer AR; Vishwanathan P; Menon VP
J Biochem Mol Toxicol; 2008; 22(2):101-12. PubMed ID: 18418896
[TBL] [Abstract][Full Text] [Related]
14. Ellagic acid in suppressing in vivo and in vitro oxidative stresses.
Zeb A
Mol Cell Biochem; 2018 Nov; 448(1-2):27-41. PubMed ID: 29388153
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-A(y) mice.
Yoshimura Y; Nishii S; Zaima N; Moriyama T; Kawamura Y
Biochem Biophys Res Commun; 2013 May; 434(3):486-91. PubMed ID: 23583377
[TBL] [Abstract][Full Text] [Related]
16. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
Dong H; Yang X; Xie J; Xiang L; Li Y; Ou M; Chi T; Liu Z; Yu S; Gao Y; Chen J; Shao J; Jia L
Biochem Pharmacol; 2015 Jan; 93(2):151-62. PubMed ID: 25522955
[TBL] [Abstract][Full Text] [Related]
17. Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review.
Alfei S; Turrini F; Catena S; Zunin P; Grilli M; Pittaluga AM; Boggia R
Eur J Med Chem; 2019 Dec; 183():111724. PubMed ID: 31563012
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways.
Lee JH; Won JH; Choi JM; Cha HH; Jang YJ; Park S; Kim HG; Kim HC; Kim DK
J Agric Food Chem; 2014 Oct; 62(41):10110-7. PubMed ID: 25238033
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability and antioxidant profile of ellagic acid by phospholipids.
Murugan V; Mukherjee K; Maiti K; Mukherjee PK
J Agric Food Chem; 2009 Jun; 57(11):4559-65. PubMed ID: 19449806
[TBL] [Abstract][Full Text] [Related]
20. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
